CopyMark Law Group
4.9/5
Drawing for OBIO

USPTO serial 97431145

OBIO

Reviewed by CopyMark Law Group

Reg. 7104966Status 700Registered
Filing date
Status date
Registration date
Jul 11, 2023
Examiner
YE, CINDY K
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

NAZLY AILEEN BAYRAMOGLU BAYRAMOGLU LAW OFFICES LLC1540 WEST WARM SPRINGS ROAD SUITE 100HENDERSON, NV 89014UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Provision of technical information in the field of gene and cell therapy, namely, laboratory scientific research services being vector design, viral packaging and functional genomics research services for academic researchers and gene therapy developers at pre-clinical stage; Providing information in the field of shortening and optimizing research and development times for researchers; Testing, inspection, research, or development of pharmaceutical preparations for gene and cell therapy; providing laboratory research services in the field of gene functional research, drug efficacy research or early development of genetic drugs; product quality testing services for gene therapy products; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of cell and gene therapy; Development of new technology for others in the field of genomics, biotechnologyACTIVEMay 31, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 21, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 21, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 21, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 14, 2023DOCKASSIGNED TO EXAMINER—
Jun 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 30, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance